These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 24757520)

  • 21. The role of cGAS-STING signalling in liver diseases.
    Chen R; Du J; Zhu H; Ling Q
    JHEP Rep; 2021 Oct; 3(5):100324. PubMed ID: 34381984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway.
    Ding C; Song Z; Shen A; Chen T; Zhang A
    Acta Pharm Sin B; 2020 Dec; 10(12):2272-2298. PubMed ID: 33354501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytosolic sensing of aberrant DNA: arming STING on the endoplasmic reticulum.
    Wang Q; Liu X; Zhou Q; Wang C
    Expert Opin Ther Targets; 2015; 19(10):1397-409. PubMed ID: 26220155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STING-dependent cytosolic DNA sensing pathways.
    Barber GN
    Trends Immunol; 2014 Feb; 35(2):88-93. PubMed ID: 24309426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways.
    Liu Y; Li J; Chen J; Li Y; Wang W; Du X; Song W; Zhang W; Lin L; Yuan Z
    J Virol; 2015 Feb; 89(4):2287-300. PubMed ID: 25505063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway.
    Bode C; Fox M; Tewary P; Steinhagen A; Ellerkmann RK; Klinman D; Baumgarten G; Hornung V; Steinhagen F
    Eur J Immunol; 2016 Jul; 46(7):1615-21. PubMed ID: 27125983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cGAS facilitates sensing of extracellular cyclic dinucleotides to activate innate immunity.
    Liu H; Moura-Alves P; Pei G; Mollenkopf HJ; Hurwitz R; Wu X; Wang F; Liu S; Ma M; Fei Y; Zhu C; Koehler AB; Oberbeck-Mueller D; Hahnke K; Klemm M; Guhlich-Bornhof U; Ge B; Tuukkanen A; Kolbe M; Dorhoi A; Kaufmann SH
    EMBO Rep; 2019 Apr; 20(4):. PubMed ID: 30872316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy.
    Wilson DR; Sen R; Sunshine JC; Pardoll DM; Green JJ; Kim YJ
    Nanomedicine; 2018 Feb; 14(2):237-246. PubMed ID: 29127039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice.
    Skouboe MK; Knudsen A; Reinert LS; Boularan C; Lioux T; Perouzel E; Thomsen MK; Paludan SR
    PLoS Pathog; 2018 Apr; 14(4):e1006976. PubMed ID: 29608601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A synthetic STING agonist inhibits the replication of human parainfluenza virus 3 and rhinovirus 16 through distinct mechanisms.
    Zhu Q; Hu H; Liu H; Shen H; Yan Z; Gao L
    Antiviral Res; 2020 Nov; 183():104933. PubMed ID: 32949635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.
    Vyskocil S; Cardin D; Ciavarri J; Conlon J; Cullis C; England D; Gershman R; Gigstad K; Gipson K; Gould A; Greenspan P; Griffin R; Gulavita N; Harrison S; Hu Z; Hu Y; Hata A; Huang J; Huang SC; Janowick D; Jones M; Kolev V; Langston SP; Lee HM; Li G; Lok D; Ma L; Mai D; Malley J; Matsuda A; Mizutani H; Mizutani M; Molchanova N; Nunes E; Pusalkar S; Renou C; Rowland S; Sato Y; Shaw M; Shen L; Shi Z; Skene R; Soucy F; Stroud S; Xu H; Xu T; Abu-Yousif AO; Zhang J
    J Med Chem; 2021 May; 64(10):6902-6923. PubMed ID: 34000802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The GRA15 protein from
    Wang P; Li S; Zhao Y; Zhang B; Li Y; Liu S; Du H; Cao L; Ou M; Ye X; Li P; Gao X; Wang P; Jing C; Shao F; Yang G; You F
    J Biol Chem; 2019 Nov; 294(45):16494-16508. PubMed ID: 31416833
    [No Abstract]   [Full Text] [Related]  

  • 33. Opposing roles of Toll-like receptor and cytosolic DNA-STING signaling pathways for Staphylococcus aureus cutaneous host defense.
    Scumpia PO; Botten GA; Norman JS; Kelly-Scumpia KM; Spreafico R; Ruccia AR; Purbey PK; Thomas BJ; Modlin RL; Smale ST
    PLoS Pathog; 2017 Jul; 13(7):e1006496. PubMed ID: 28704551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy.
    Miyabe H; Hyodo M; Nakamura T; Sato Y; Hayakawa Y; Harashima H
    J Control Release; 2014 Jun; 184():20-7. PubMed ID: 24727060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensing of Bacterial Cyclic Dinucleotides by the Oxidoreductase RECON Promotes NF-κB Activation and Shapes a Proinflammatory Antibacterial State.
    McFarland AP; Luo S; Ahmed-Qadri F; Zuck M; Thayer EF; Goo YA; Hybiske K; Tong L; Woodward JJ
    Immunity; 2017 Mar; 46(3):433-445. PubMed ID: 28329705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive feedback regulation of type I interferon by the interferon-stimulated gene STING.
    Ma F; Li B; Yu Y; Iyer SS; Sun M; Cheng G
    EMBO Rep; 2015 Feb; 16(2):202-12. PubMed ID: 25572843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Emerging Roles of STING in Bacterial Infections.
    Marinho FV; Benmerzoug S; Oliveira SC; Ryffel B; Quesniaux VFJ
    Trends Microbiol; 2017 Nov; 25(11):906-918. PubMed ID: 28625530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity.
    Dane EL; Belessiotis-Richards A; Backlund C; Wang J; Hidaka K; Milling LE; Bhagchandani S; Melo MB; Wu S; Li N; Donahue N; Ni K; Ma L; Okaniwa M; Stevens MM; Alexander-Katz A; Irvine DJ
    Nat Mater; 2022 Jun; 21(6):710-720. PubMed ID: 35606429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pam
    Hu HG; Wu JJ; Zhang BD; Li WH; Li YM
    Bioconjug Chem; 2020 Nov; 31(11):2499-2503. PubMed ID: 33147965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
    Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
    FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.